Kurtz Ronald M MD
SEC CIK 1295469 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RXST | RxSight, Inc. | See Remarks, Dir | 71.8K | $2.05M | $7.72M | 11 | 2021-08-03 | 2026-09-02 |
Most active insiders at RXST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wilterding Mark | CFO | — | $54.0K |
| 2 | Kurtz Ronald M MD | Chief Medical Off | — | $35.5K |
| 3 | Goldshleger Ilya | See remarks | — | $14.2K |
| 4 | Weinberg Eric | See remarks | — | $14.2K |
| 5 | Gaines Scott | Chief Customer Off | — | — |
| 6 | Fountain Tamara | Dir | — | — |
| 7 | Corley Jesse Anderson | Dir | — | — |
| 8 | Warner Robert Keith | Dir | — | — |
| 9 | Maniar Shweta | Dir | — | — |
| 10 | Andrews Julie | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-02 21:35 | 2026-08-31 | RXST | RxSight, Inc. | Kurtz Ronald M MD | Chief Medical Off | M - OptEx | — | +13.4K | 76.9K | +21% | — |
| D | 2026-09-02 21:35 | 2026-09-02 | RXST | RxSight, Inc. | Kurtz Ronald M MD | Chief Medical Off | S - Sale+OE | $6.96 | -5,100 | 71.8K | -7% | -$35.5K |
| DM | 2024-08-09 | 2024-08-09 | RXST | RxSight, Inc. | Kurtz Ronald M MD | Pres, CEO, Dir | M - OptEx | $12.60 | +9,950 | 61.1K | +19% | +$125.3K |
| D | 2024-07-12 | 2024-07-11 | RXST | RxSight, Inc. | Kurtz Ronald M MD | Pres, CEO, Dir | M - OptEx | $15.08 | +13.5K | 53.5K | +34% | +$203.6K |
| TI | 2024-05-06 | 2024-05-03 | RXST | RxSight, Inc. | Kurtz Ronald M MD | Pres, CEO, Dir | S - Sale | $60.15 | -40.0K | 764.6K | -5% | -$2.41M |
| MTI | 2024-01-09 | 2024-01-08 | RXST | RxSight, Inc. | Kurtz Ronald M MD | Pres, CEO, Dir | S - Sale | $44.25 | -62.5K | 804.6K | -7% | -$2.77M |
| I | 2023-12-29 | 2023-12-27 | RXST | RxSight, Inc. | Kurtz Ronald M MD | Pres, CEO, Dir | S - Sale | $41.09 | -22.5K | 867.1K | -3% | -$924.5K |
| MI | 2023-12-18 | 2023-12-14 | RXST | RxSight, Inc. | Kurtz Ronald M MD | Pres, CEO, Dir | S - Sale | $39.70 | -40.0K | 909.6K | -4% | -$1.59M |
| 2023-02-13 | 2023-02-10 | RXST | RxSight, Inc. | Kurtz Ronald M MD | Pres, CEO, Dir | A - Grant | $12.50 | +40.0K | 40.0K | New | +$500.0K | |
| 2021-08-05 | 2021-08-03 | RXST | RxSight, Inc. | Kurtz Ronald M MD | See Remarks, Dir | P - Purchase | $16.00 | +125.0K | 125.0K | New | +$2.00M | |
| I | 2021-08-05 | 2021-08-05 | RXST | RxSight, Inc. | Kurtz Ronald M MD | See Remarks, Dir | P - Purchase | $13.85 | +3,638 | 804.6K | +0.5% | +$50.4K |
Purchase Sale Sale after option exercise All abbreviations